Another interesting study reported that E2 reduced the level of CCL2 in the placenta to control inflammation and further treat preeclampsia (PE) via estrogen receptor Α36 (ERΑ36)-induced toll-like receptor 4 (TLR4) pathways (46). This evidence concerns the gene TLR4 and preeclampsia.